Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Yahfoufi N, Alsadi N, Jambi M, Matar C
In June 2026 the MHRA approved oral semaglutide, marketed as the Wegovy pill, the first oral GLP-1 medicine licensed in the UK for weight management
MC3R: Expressed in various tissues, including the brain and placenta, implicated in regulating appetite and energy homeostasis
Supports General Wellness: A smart addition to your daily routine to help maintain balanced nutrition and everyday vitality.*
Retatrutide is a novel triple receptor agonist peptide that targets the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R)
US$ 26.23
US$ 25.99
US$ 26.11
US$ 23.79
